The trajectory of Viagra, formerly marketed by copyright, presents a intricate case study for investors considering the pharmaceutical landscape . Although its early success and generation of countless in revenue , the patent lapse has opened the door for competing medications, substantially diminishing income potential . This shift raises doubts a